What is the role for interleukin-1 receptor antagonist in rheumatic disease?

被引:6
|
作者
Lequerre, Thierry [1 ]
Vittecoq, Olivier [1 ]
le Loet, Xavier [1 ]
机构
[1] CHU, Rouen Teaching Hosp, Hop Boisguillaume,IFRMP 23, Dept Rheumatol,INSERM Unit 519, F-76031 Rouen, France
关键词
D O I
10.1016/j.jbspin.2006.10.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:223 / 226
页数:4
相关论文
共 50 条
  • [21] Association of interleukin-1β and interleukin-1 receptor antagonist genes with disease severity in MS
    Schrijver, HM
    Crusius, JBA
    Uitdehaag, BMJ
    González, MAG
    Kostense, PJ
    Polman, CH
    Peña, AS
    NEUROLOGY, 1999, 52 (03) : 595 - 599
  • [22] ROLE OF INTERLEUKIN-1 RECEPTOR ANTAGONIST IN INFLAMMATORY BOWEL-DISEASE (IBD)
    MITSUYAMA, K
    TOYONAGA, A
    SASAKI, E
    NISHIYAMA, T
    TSURUTA, O
    HARADA, K
    TORIMURA, T
    TANIKAWA, K
    GASTROENTEROLOGY, 1993, 104 (04) : A747 - A747
  • [23] Graves' ophthalmopathy and gene polymorphisms in interleukin-1α, interleukin-1β, interleukin-1 receptor and interleukin-1 receptor antagonist
    Khalilzadeh, Omid
    Anvari, Mehdi
    Esteghamati, Alireza
    Mahmoudi, Mahdi
    Tahvildari, Maryam
    Rashidi, Armin
    Khosravi, Farideh
    Amirzargar, Aliakbar
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2009, 37 (06): : 614 - 619
  • [24] A Functional Interleukin-1 Receptor Antagonist Polymorphism Influences Atherosclerosis Development - The Interleukin-1β:Interleukin-1 Receptor Antagonist Balance in Atherosclerosis -
    Olofsson, Peder S.
    Sheikine, Yuri
    Jatta, Ken
    Ghaderi, Mehran
    Samnegard, Ann
    Eriksson, Per
    Sirsjoe, Allan
    CIRCULATION JOURNAL, 2009, 73 (08) : 1531 - 1536
  • [25] Mucosal imbalance of interleukin-1β and interleukin-1 receptor antagonist in canine inflammatory bowel disease
    Maeda, Shingo
    Ohno, Koichi
    Nakamura, Kenji
    Uchida, Kazuyuki
    Nakashima, Ko
    Fukushima, Kenjiro
    Tsukamoto, Atsushi
    Goto-Koshino, Yuko
    Fujino, Yasuhito
    Tsujimoto, Hajime
    VETERINARY JOURNAL, 2012, 194 (01): : 66 - 70
  • [26] Investigation of the role of interleukin-1 receptor antagonist VNTR variant on the Behcet's disease
    Dursun, Gul
    Nursal, Ayse Feyda
    Demir, Helin Deniz
    Karakus, Nevin
    Demir, Osman
    Yigit, Serbulent
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2018, 5 (01) : 27 - 31
  • [27] Role of intracellular interleukin-1 receptor antagonist in skin carcinogenesis
    La, EH
    Rundhaug, JE
    Fischer, SM
    MOLECULAR CARCINOGENESIS, 2001, 30 (04) : 218 - 223
  • [28] Influence of interleukin-1 receptor antagonist gene polymorphism on disease
    Witkin, SS
    Gerber, S
    Ledger, WJ
    CLINICAL INFECTIOUS DISEASES, 2002, 34 (02) : 204 - 209
  • [29] INTERLEUKIN-1 RECEPTOR ANTAGONIST - EFFECTIVENESS AGAINST INTERLEUKIN-1 FEVER
    COCEANI, F
    LEES, J
    REDFORD, J
    BISHAI, I
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1992, 70 (12) : 1590 - 1596
  • [30] Interleukin-1 and interleukin-1 receptor antagonist in systemic lupus erythematosus
    Chang, DM
    IMMUNOLOGICAL INVESTIGATIONS, 1997, 26 (5-7) : 649 - 659